{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:29:32Z","timestamp":1787318972866,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Latent tuberculosis (TB) infection has been known as a seedbed for TB disease later in life. The interruption from latent TB infection to TB disease can be done through TB preventive treatment (TPT). In Cambodia, only 40.0% of children under five years old who were the household contacts to bacteriologically confirmed TB cases were initiated with TPT in 2021. Scientific studies of context-specific operational challenges in TPT provision and uptake among children are scarce, particularly in high TB-burden countries. This study identified challenges in TPT provision and uptake among children in Cambodia from the perspective of healthcare providers and caregivers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between October and December 2020, we conducted in-depth interviews with four operational district TB supervisors, four clinicians and four nurses in charge of TB in referral hospitals, four nurses in charge of TB in health centers, and 28 caregivers with children currently or previously on TB treatment or TPT, and those who refused TPT for their eligible children. Data were audio recorded along with field notetaking. After verbatim transcription, data analyses were performed using a thematic approach.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The mean age of healthcare providers and caregivers were 40.19\u00a0years (SD 12.0) and 47.9\u00a0years (SD 14.6), respectively. Most healthcare providers (93.8%) were male, and 75.0% of caregivers were female. More than one-fourth of caregivers were grandparents, and 25.0% had no formal education. Identified key barriers to TPT implementation among children included TPT side effects, poor adherence to TPT,\u00a0poor understanding of TPT among caregivers, TPT risk perception among caregivers, TPT\u2019s child-unfriendly formula, TPT supply-chain issues, caregivers\u2019 concern about the effectiveness of TPT, being non-parental caregivers, and poor community engagement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Findings from this study suggest that the national TB program should provide more TPT training to healthcare providers and strengthen supply chain mechanisms to ensure adequate TPT drug supplies. Improving community awareness of TPT among caregivers should also be intensified. These context-specific interventions will play a crucial role in expanding the TPT program to interrupt the development from latent TB infection to active and ultimately lead to ending TB in the country.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12890-023-02379-7","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:20:07Z","timestamp":1679847607000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["They do not have symptoms \u2013 why do they need to take medicines? Challenges in tuberculosis preventive treatment among children in Cambodia: a qualitative study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yom","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Kuo Jing","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan Yuda","family":"Huot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sivanna","family":"Tieng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Eam","family":"Khun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sok Heng","family":"Pheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chhenglay","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serongkea","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ngak","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Nonaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"2379_CR1","volume-title":"Tuberculosis profile: Cambodia","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. Tuberculosis profile: Cambodia. Geneva: World Health Organization; 2020."},{"issue":"3","key":"2379_CR2","first-page":"278","volume":"8","author":"BJ Marais","year":"2004","unstructured":"Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Nelson LJ, et al. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era [State of the Art]. Int J Tuberc Lung Dis. 2004;8(3):278\u201385.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"1","key":"2379_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-14-91","volume":"14","author":"J Ayieko","year":"2014","unstructured":"Ayieko J, Abuogi L, Simchowitz B, Bukusi EA, Smith AH, Reingold A. Efficacy of isoniazid prophylactic therapy in prevention of tuberculosis in children: a meta\u2013analysis. BMC Infect Dis. 2014;14(1):1\u201310.","journal-title":"BMC Infect Dis"},{"key":"2379_CR4","volume-title":"WHO operational handbook on tuberculosis. Module 1: prevention-tuberculosis preventive treatment","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO operational handbook on tuberculosis. Module 1: prevention-tuberculosis preventive treatment. Geneva, Switzerland: World Health Organization; 2020."},{"key":"2379_CR5","volume-title":"Global tuberculosis report 2021. World Health Organization","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Global tuberculosis report 2021. World Health Organization. Geneva, Switzerland; 2021. (Licence: CC BY-NC-SA 3.0 IGO)."},{"key":"2379_CR6","volume-title":"Latent tuberculosis infection: updated and consolidated guidelines for programmatic management","author":"World Health Organization","year":"2018","unstructured":"World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva, Switzerland: World Health Organization; 2018."},{"issue":"2","key":"2379_CR7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5588\/ijtld.16.0624","volume":"21","author":"S Chiang","year":"2017","unstructured":"Chiang S, Roche S, Contreras C, Del Castillo H, Canales P, Jimenez J, et al. Barriers to the treatment of childhood tuberculous infection and tuberculosis disease: a qualitative study. Int J Tuberc Lung Dis. 2017;21(2):154\u201360.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"4","key":"2379_CR8","first-page":"274","volume":"63","author":"AR Singh","year":"2017","unstructured":"Singh AR, Kharate A, Bhat P, Kokane AM, Bali S, Sahu S, et al. Isoniazid preventive therapy among children living with tuberculosis patients: is it working? A mixed-method study from Bhopal. India J Trop Pediatr. 2017;63(4):274\u201385.","journal-title":"India J Trop Pediatr"},{"issue":"12","key":"2379_CR9","first-page":"1507","volume":"13","author":"V BanuRekha","year":"2009","unstructured":"BanuRekha V, Jagarajamma K, Wares F, Chandrasekaran V, Swaminathan S. Contact screening and chemoprophylaxis in India\u2019s revised tuberculosis control programme: a situational analysis. Int J Tuberc Lung Dis. 2009;13(12):1507\u201312.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2379_CR10","doi-asserted-by":"crossref","unstructured":"Birungi FM, Graham S, Uwimana J, van Wyk B. Assessment of the isoniazid preventive therapy uptake and associated characteristics: a cross-sectional study. Tuberc Res Treat. 2018.\u00a0https:\/\/downloads.hindawi.com\/journals\/trt\/2018\/8690714.pdf.","DOI":"10.1155\/2018\/8690714"},{"issue":"10","key":"2379_CR11","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1111\/j.1365-3156.2012.03053.x","volume":"17","author":"ME Rutherford","year":"2012","unstructured":"Rutherford ME, Hill PC, Triasih R, Sinfield R, van Crevel R, Graham SM. Preventive therapy in children exposed to Mycobacterium tuberculosis: problems and solutions. Trop Med Int Health. 2012;17(10):1264\u201373.","journal-title":"Trop Med Int Health"},{"issue":"10","key":"2379_CR12","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.5588\/ijtld.17.0848","volume":"22","author":"V Belgaumkar","year":"2018","unstructured":"Belgaumkar V, Chandanwale A, Valvi C, Pardeshi G, Lokhande R, Kadam D, et al. Barriers to screening and isoniazid preventive therapy for child contacts of tuberculosis patients. Int J Tuberc Lung Dis. 2018;22(10):1179\u201387.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"12","key":"2379_CR13","doi-asserted-by":"publisher","first-page":"e024286","DOI":"10.1136\/bmjopen-2018-024286","volume":"8","author":"EOA Wambiya","year":"2018","unstructured":"Wambiya EOA, Atela M, Eboreime E, Ibisomi L. Factors affecting the acceptability of isoniazid preventive therapy among healthcare providers in selected HIV clinics in Nairobi County, Kenya: a qualitative study. BMJ Open. 2018;8(12):e024286.","journal-title":"BMJ Open"},{"issue":"11","key":"2379_CR14","first-page":"1033","volume":"7","author":"R Zachariah","year":"2003","unstructured":"Zachariah R, Spielmann M, Harries A, Gomani P, Graham S, Bakali E, et al. Passive versus active tuberculosis case finding and isoniazid preventive therapy among household contacts in a rural district of Malawi. Int J Tuberc Lung Dis. 2003;7(11):1033\u20139.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2379_CR15","volume-title":"Global tuberculosis report 2022","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization; 2022."},{"key":"2379_CR16","volume-title":"National Strategic Plan to End Tuberculosis in Cambodia 2021- 2030","author":"The National Centre for Tuberculosis and Leprosy Control (CENAT)","year":"2021","unstructured":"The National Centre for Tuberculosis and Leprosy Control (CENAT). National Strategic Plan to End Tuberculosis in Cambodia 2021- 2030. Phnom Penh, Cambodia: The National Centre for Tuberculosis and Leprosy Control; 2021."},{"key":"2379_CR17","volume-title":"National guideline for diagnosis and treatment of TB in children","author":"The National Centre for Tuberculosis and Leprosy Control (CENAT)","year":"2008","unstructured":"The National Centre for Tuberculosis and Leprosy Control (CENAT). National guideline for diagnosis and treatment of TB in children. Phnom Penh, Cambodia: The National Centre for Tuberculosis and Leprosy Control; 2008."},{"key":"2379_CR18","volume-title":"Programatic management of latent TB infection (LTBI): Standard operation procedure for LTBI management and TB preventive therapy (TPT)","author":"The National Centre for Tuberculosis and Leprosy Control (CENAT)","year":"2020","unstructured":"The National Centre for Tuberculosis and Leprosy Control (CENAT). Programatic management of latent TB infection (LTBI): Standard operation procedure for LTBI management and TB preventive therapy (TPT). Phnom Penh, Cambodia: The National Centre for Tuberculosis and Leprosy Control; 2020."},{"issue":"1","key":"2379_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-021-07004-8","volume":"22","author":"Y An","year":"2022","unstructured":"An Y, Teo AKJ, Huot CY, Tieng S, Khun KE, Pheng SH, et al. Knowledge, attitude, and practices regarding childhood tuberculosis detection and management among health care providers in Cambodia: a cross-sectional study. BMC Infect Dis. 2022;22(1):1\u201311.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"2379_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-020-05324-0","volume":"20","author":"Y Hirsch-Moverman","year":"2020","unstructured":"Hirsch-Moverman Y, Mantell JE, Lebelo L, Howard AA, Hesseling AC, Nachman S, et al. Provider attitudes about childhood tuberculosis prevention in Lesotho: a qualitative study. BMC Health Serv Res. 2020;20(1):1\u20138.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"2379_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ijtb.2021.03.005","volume":"69","author":"N Sharma","year":"2022","unstructured":"Sharma N, Basu S, Khanna A, Sharma P, Chopra KK, Chandra S. Adherence to isoniazid preventive therapy among children living with tuberculosis patients in Delhi, India: an exploratory prospective study. Indian Journal of Tuberculosis. 2022;69(1):100\u20133.","journal-title":"Indian Journal of Tuberculosis"},{"issue":"2","key":"2379_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.5588\/ijtld.12.0415","volume":"17","author":"B Rekha","year":"2013","unstructured":"Rekha B, Jagarajamma K, Chandrasekaran V, Wares F, Sivanandham R, Swaminathan S. Improving screening and chemoprophylaxis among child contacts in India\u2019s RNTCP: a pilot study. Int J Tuberc Lung Dis. 2013;17(2):163\u20138.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"8","key":"2379_CR23","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.5588\/ijtld.15.0952","volume":"20","author":"R Triasih","year":"2016","unstructured":"Triasih R, Padmawati R, Duke T, Robertson C, Sawyer S, Graham S. A mixed-methods evaluation of adherence to preventive treatment among child tuberculosis contacts in Indonesia. Int J Tuberc Lung Dis. 2016;20(8):1078\u201383.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2379_CR24","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ijid.2016.11.006","volume":"56","author":"G Fox","year":"2017","unstructured":"Fox G, Dobler C, Marais B, Denholm J. Preventive therapy for latent tuberculosis infection\u2014the promise and the challenges. Int J Infect Dis. 2017;56:68\u201376.","journal-title":"Int J Infect Dis"},{"issue":"2","key":"2379_CR25","doi-asserted-by":"publisher","first-page":"e20172838","DOI":"10.1542\/peds.2017-2838","volume":"141","author":"AT Cruz","year":"2018","unstructured":"Cruz AT, Starke JR. Completion rate and safety of tuberculosis infection treatment with shorter regimens. Pediatrics. 2018;141(2):e20172838.","journal-title":"Pediatrics"},{"issue":"5","key":"2379_CR26","doi-asserted-by":"publisher","first-page":"382","DOI":"10.5588\/ijtld.20.0941","volume":"25","author":"S Satyanarayana","year":"2021","unstructured":"Satyanarayana S, Bhatia V, Mandal P, Kanchar A, Falzon D, Sharma M. Urgent need to address the slow scale-up of TB preventive treatment in the WHO South-East Asia region. Int J Tuberc Lung Dis. 2021;25(5):382\u20137.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2379_CR27","doi-asserted-by":"publisher","first-page":"932","DOI":"10.2471\/BLT.13.118414","volume":"91","author":"ME Rutherford","year":"2013","unstructured":"Rutherford ME, Ruslami R, Anselmo M, Alisjahbana B, Yulianti N, Sampurno H, et al. Management of children exposed to Mycobacterium tuberculosis: a public health evaluation in West Java, Indonesia. Bull World Health Organ. 2013;91:932\u201341.","journal-title":"Bull World Health Organ"},{"issue":"1","key":"2379_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1756-0500-5-7","volume":"5","author":"ME Rutherford","year":"2012","unstructured":"Rutherford ME, Ruslami R, Maharani W, Yulita I, Lovell S, Van Crevel R, et al. Adherence to isoniazid preventive therapy in Indonesian children: A quantitative and qualitative investigation. BMC Res Notes. 2012;5(1):7.","journal-title":"BMC Res Notes"},{"issue":"2","key":"2379_CR29","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1467-842X.1998.tb01174.x","volume":"22","author":"G Alperstein","year":"1998","unstructured":"Alperstein G, Morgan KR, Mills K, Daniels L. Compliance with anti-tuberculosis preventive therapy among 6-year-old children. Aust N Z J Public Health. 1998;22(2):210\u20133.","journal-title":"Aust N Z J Public Health"},{"issue":"6","key":"2379_CR30","doi-asserted-by":"publisher","first-page":"e0129135","DOI":"10.1371\/journal.pone.0129135","volume":"10","author":"D Assefa","year":"2015","unstructured":"Assefa D, Klinkenberg E, Yosef G. Cross sectional study evaluating routine contact investigation in Addis Ababa, Ethiopia: a missed opportunity to prevent tuberculosis in children. PLoS ONE. 2015;10(6):e0129135.","journal-title":"PLoS ONE"},{"key":"2379_CR31","first-page":"8690714","volume":"2018","author":"FM Birungi","year":"2018","unstructured":"Birungi FM, Graham S, Uwimana J, van Wyk B. Assessment of the isoniazid preventive therapy uptake and associated characteristics: a cross-sectional study. Tuberc Res Treat. 2018;2018:8690714.","journal-title":"Tuberc Res Treat"},{"issue":"2","key":"2379_CR32","doi-asserted-by":"publisher","first-page":"e0211934","DOI":"10.1371\/journal.pone.0211934","volume":"14","author":"FM Birungi","year":"2019","unstructured":"Birungi FM, Graham SM, Uwimana J, Musabimana A, van Wyk B. Adherence to isoniazid preventive therapy among child contacts in Rwanda: a mixed-methods study. PLoS ONE. 2019;14(2):e0211934.","journal-title":"PLoS ONE"},{"issue":"3","key":"2379_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.5588\/pha.13.0010","volume":"3","author":"D Skinner","year":"2013","unstructured":"Skinner D, Hesseling A, Francis C, Mandalakas A. It\u2019s hard work, but it\u2019s worth it: the task of keeping children adherent to isoniazid preventive therapy. Public Health Action. 2013;3(3):191\u20138.","journal-title":"Public Health Action"},{"issue":"4","key":"2379_CR34","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1080\/17441692.2021.1892793","volume":"17","author":"DK Chandra","year":"2022","unstructured":"Chandra DK, Moll AP, Altice FL, Didomizio E, Andrews L, Shenoi SV. Structural barriers to implementing recommended tuberculosis preventive treatment in primary care clinics in rural South Africa. Glob Public Health. 2022;17(4):555\u201368.","journal-title":"Glob Public Health"},{"issue":"1","key":"2379_CR35","doi-asserted-by":"publisher","first-page":"1979281","DOI":"10.1080\/16549716.2021.1979281","volume":"14","author":"AA Ahmed","year":"2021","unstructured":"Ahmed AA, Grammatico M, Moll AP, Malinga S, Makhunga P, Charalambous S, et al. Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa. Glob Health Action. 2021;14(1):1979281.","journal-title":"Glob Health Action"},{"issue":"1","key":"2379_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-022-07333-2","volume":"22","author":"GI Benoit V\u00e1squez","year":"2022","unstructured":"Benoit V\u00e1squez GI, Morrobel AL, Benjumea-Bedoya D, del Corral-Londo\u00f1o H. Barriers and facilitators for isoniazid preventive therapy (IPT) administration in children under 5 years of age in the Dominican Republic. BMC Infect Dis. 2022;22(1):1\u201312.","journal-title":"BMC Infect Dis"},{"issue":"11","key":"2379_CR37","doi-asserted-by":"publisher","first-page":"e26452","DOI":"10.1371\/journal.pone.0026452","volume":"6","author":"KT Garie","year":"2011","unstructured":"Garie KT, Yassin MA, Cuevas LE. Lack of adherence to isoniazid chemoprophylaxis in children in contact with adults with tuberculosis in Southern Ethiopia. PLoS ONE. 2011;6(11):e26452.","journal-title":"PLoS ONE"},{"key":"2379_CR38","unstructured":"The National Centre for Tuberculosis and Leprosy Control (CENAT). Cambodia TB MIS, TB Management Information System The National Centre for Tuberculosis and Leprosy Control, Phnom Penh, Cambodia.\u00a02022. Available from: http:\/\/camtbmis.org\/etbmanager\/home.seam."},{"issue":"11","key":"2379_CR39","first-page":"1","volume":"30","author":"NI Paul","year":"2019","unstructured":"Paul NI, Gabriel-Job N. Adherence to isoniazid preventive therapy (IPT) among children in close contact with adult pulmonary tuberculosis (PTB) patients. J Adv Med Med Res. 2019;30(11):1\u20138.","journal-title":"J Adv Med Med Res"},{"key":"2379_CR40","unstructured":"World Health Organization. Community engagement: a health promotion guide for universal health coverage in the hands of the people. 2020."},{"issue":"12","key":"2379_CR41","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.5588\/ijtld.19.0018","volume":"23","author":"D Surie","year":"2019","unstructured":"Surie D, Interrante J, Pathmanathan I, Patel M, Anyalechi G, Cavanaugh J, et al. Policies, practices and barriers to implementing tuberculosis preventive treatment\u201435 countries, 2017. Int J Tuberc Lung Dis. 2019;23(12):1308\u201313.","journal-title":"Int J Tuberc Lung Dis"},{"key":"2379_CR42","unstructured":"World Health Organization. A situational analysis of programmatic management of TB preventive treatment in the WHO South-East Asia Region. 2020."},{"key":"2379_CR43","volume-title":"WHO consolidated guidelines on tuberculosis: module 1: prevention- tuberculosis preventive treatment:","author":"World Health Organization","year":"2020","unstructured":"World Health Organization. WHO consolidated guidelines on tuberculosis: module 1: prevention- tuberculosis preventive treatment: Geneva, Switzerland: World Health Organization; 2020. (Licence: CC BY-NC-SA 3.0 IGO)."},{"key":"2379_CR44","volume-title":"Global tuberculosis report 2021","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. Global tuberculosis report 2021. Geneva: World Health Organization; 2021."}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-023-02379-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-023-02379-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T16:20:31Z","timestamp":1679847631000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-023-02379-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2379"],"URL":"https:\/\/doi.org\/10.1186\/s12890-023-02379-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2037057\/v1","asserted-by":"object"}]},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"6 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the National Ethics Committee for Health Research (NECHR) (ref. 234\/NECHR) in Cambodia and the Ethics Review Committee of the World Health Organization Western Pacific Regional Office (ID: 2020.8.CAM.3.STB). All methods were carried out in accordance with the Declaration of Helsinki, and informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"83"}}